TY - JOUR
T1 - Immune activation in irritable bowel syndrome
T2 - Can neuroimmune interactions explain symptoms
AU - Hughes, Patrick A.
AU - Zola, Heddy
AU - Penttila, Irmeli A.
AU - Blackshaw, L. Ashley
AU - Andrews, Jane M.
AU - Krumbiegel, Doreen
N1 - Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2013/7
Y1 - 2013/7
N2 - Irritable bowel syndrome (IBS) is a functional disorder o. The gastrointestinal (GI) tract characterized by pain or discomfort fro. The lower abdominal region, which is associated with altered bowel habit. Despite its prevalence, there is currently a lack of effective treatment options for patients. IBS has long been considered as a neurological condition resulting from alterations i. The brain gut axis, but immunological alterations are increasingly reported in IBS patients, consistent wit. The hypothesis that there is a chronic, but low-grade, immune activation. Mediators released by immune cells act to either dampen or amplif. The activity of GI nerves. Release of a number of these mediators correlates with symptoms of IBS, highlightin. The importance of interactions betwee. The immune an. The nervous systems. Investigation o. The role of microbiota in these interactions is in its early stages, but may provide many answers regardin. The mechanisms underlying activation o. The immune system in IBS. Identifying wha. The key changes i. The GI immune system are in IBS and how these changes modulate viscerosensory nervous function is essential fo. The development of novel therapies fo. The underlying disorder.
AB - Irritable bowel syndrome (IBS) is a functional disorder o. The gastrointestinal (GI) tract characterized by pain or discomfort fro. The lower abdominal region, which is associated with altered bowel habit. Despite its prevalence, there is currently a lack of effective treatment options for patients. IBS has long been considered as a neurological condition resulting from alterations i. The brain gut axis, but immunological alterations are increasingly reported in IBS patients, consistent wit. The hypothesis that there is a chronic, but low-grade, immune activation. Mediators released by immune cells act to either dampen or amplif. The activity of GI nerves. Release of a number of these mediators correlates with symptoms of IBS, highlightin. The importance of interactions betwee. The immune an. The nervous systems. Investigation o. The role of microbiota in these interactions is in its early stages, but may provide many answers regardin. The mechanisms underlying activation o. The immune system in IBS. Identifying wha. The key changes i. The GI immune system are in IBS and how these changes modulate viscerosensory nervous function is essential fo. The development of novel therapies fo. The underlying disorder.
UR - http://www.scopus.com/inward/record.url?scp=84880296547&partnerID=8YFLogxK
U2 - 10.1038/ajg.2013.120
DO - 10.1038/ajg.2013.120
M3 - Article
C2 - 23649183
AN - SCOPUS:84880296547
SN - 0002-9270
VL - 108
SP - 1066
EP - 1074
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 7
ER -